At Novo Nordisk, we believe in change. We are parents, colleagues, neighbors and friends — people living with the complexities of serious diseases. And we believe in the combination of science and soul to help nurture each other back to good health.
For more than 100 years, we have been driving change to defeat diabetes, which has given us the experience and capability to help defeat other serious chronic diseases, including obesity, hemophilia and growth hormone disorders.
We work for a future where lives are not limited—and we do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat.
From our labs to our factory floors, we are discovering and developing innovative biological medicines and making them accessible to patients who need them.
Headquarters in Plainsboro, NJ
Employing nearly 6000 people
4 million people in the U.S. using our medicines
Our U.S. headquarters in Plainsboro, New Jersey plays a critical role in the vibrancy of the life sciences industry in New Jersey. We are responsible for sales and marketing of all Novo Nordisk products in the U.S. and manage clinical trials in the U.S. Our LEED-certified headquarters building is modeled on principles of functionality, innovation, openness, quality and aesthetics - offering a space that promotes collaboration and creativity.
Our research center in Seattle is focused on digital therapy, data science and artificial intelligence. A dedicated team of device engineers are working with digitalization and connectivity of medical devices for improved treatment outcomes.
The greater San Francisco area is a prominent medical and biotechnology research hub in the U.S., and the East Bay community of Fremont is an emerging center of leading-edge research in regenerative medicine and stem cell therapies.
Cambridge reigns as one of the world's top innovation ecosystems, as it is home to leading academic institutions, hospitals and R&D organizations.
The Novo Nordisk Cambridge location is the headquarters for the Global R&D Business Development across all of our therapeutic and technology areas.
Novo Nordisk US Bio Production, Inc. (NNUSBPI) is a biopharmaceutical manufacturing facility that works to produce trusted products for people living with the rare bleeding disorder known as hemophilia.
North Carolina's Research Triangle region is the 4th largest life science industry hub in the U.S. and offers unparalleled access to top biomanufacturing talent. The area frequently tops rankings of the best places to live and work in the country.
The Novo Nordisk Way describes the values and behaviors that guide everything we do. It is rooted in the principles and vision of our founders who set out on an ambitious journey to change diabetes in 1923.
Today, we are thousands of colleagues applying the same passion, skills and commitment to our purpose of driving change to defeat serious chronic diseases, built upon our heritage in diabetes.
Our key values of openness, accountability and respect underpin our work to drive change for a healthier world. To help us live these values, 10 Essentials guide the decisions and actions of every Novo Nordisk colleague.
- We create value by having a patient-centered business approach.
- We set ambitious goals and are empowered to achieve them.
- We are accountable for our financial, environmental, and social performance.
- We are curious and innovate for the benefit of patients and society at large.
- We build and maintain good relations with our stakeholders.
- We value diversity and treat everyone with respect.
- We focus on performance and personal development.
- We have a healthy and engaging working environment.
- We strive for agility and simplicity in everything we do.
- We never compromise on quality and ethics.
When faced with difficult choices, we think long-term, understanding that our future is dependent on being financially, environmentally and socially responsible.
It's our way. It's the Novo Nordisk Way.
We are a proud life science company united by a common job to discover better treatments for people living with a serious chronic disease.
Our industry is dynamic. And the scientific understanding of the diseases we treat and the people living with them, improves every day. This is a constant reminder that what got us to where we are today is not necessarily what will make us successful in the future.
As an employer, we recognize the need to embrace experimentation and strive for diversity and inclusion to help make better decisions by ensuring that multiple perspectives are considered.
Together, we’re life changing.
We work in close collaboration with leading universities and biotech companies worldwide to collaborate and speed up new drug discovery.
We continuously seek new partners with whom we share complementary capabilities and mutual interests, and openly share novel peptide and protein analogues, and antibodies for preclinical research.
We offer easy and free access to selected high-quality and well-characterised compounds to curious and passionate scientists from around the world.
